{"id":"W4386270668","doi":"10.1016/s2152-2650(23)00826-1","title":"POSTER: MM-374 Efficacy and Safety of Elranatamab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) and Prior B-Cell Maturation Antigen (BCMA)- Directed Therapies: Pooled Analysis From MagnetisMM Studies","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Refractory (planetary science); Oncology; Safety profile; Internal medicine; Adverse effect; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003425819,0.0008093821,0.001974467,0.0006994535,0.000258017,0.0009914138,0.0004549725,0.0007622692,0.006701305],"category_scores_gemma":[0.003457087,0.0004061439,0.00349057,0.000598229,0.0003387971,0.0005842867,0.0005303551,0.001059516,0.001034462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007871024,"about_ca_system_score_gemma":0.0007585902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006005438,"about_ca_topic_score_gemma":0.00132335,"domain_scores_codex":[0.9986653,0.0007501093,0.0001436444,0.0001520095,0.0001775288,0.0001112971],"domain_scores_gemma":[0.9984722,0.0005543542,0.0005307067,0.0001217536,0.0001559327,0.0001650832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5757179,0.001320129,0.05113107,0.005376866,0.09180254,0.0001401099,0.0000951502,0.002117458,0.01362892,0.0002520525,0.008354151,0.2500637],"study_design_scores_gemma":[0.1987545,0.1002979,0.497535,0.001468642,0.1565747,0.0008132373,0.0001879883,0.002931816,0.01333775,0.001213662,0.0266455,0.0002393777],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8582012,0.122372,0.001302922,0.002293129,0.0008891348,0.0006949877,0.007637124,0.0001648669,0.006444588],"genre_scores_gemma":[0.9787015,0.01171883,0.0007337828,0.001181418,0.0007668498,0.0002319947,0.003709703,0.00002884649,0.002926987],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006701305,"threshold_uncertainty_score":0.02241802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02350944719620967,"score_gpt":0.3104386406161649,"score_spread":0.2869291934199553,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}